I do not want to come across as negative; but there may be some items to draw from the subset report BH has posted.
IMO Admedus mgmt have recognised they need further assistance to gain market. We all know there is competition with deep pockets and a familiarity of the layout and Admedus is still navigating across native ground. Although we have a superior product, I remind you of the Beta versus VHS story.
I am comfortable with the recent appointments as they reflect a mgmt team who recognise areas for improvement and act on them.
'Top Marks'.
new report, page-10
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |